Hass

450330 · KOSDAQ · Health Care · SMALL CAP

Updated results.

Hass updated its previously filed consolidated results for FY2025: revenue of US$11.3M (+2.6% year on year), operating profit of US$614K (−27% year on year) and net income of US$1.09M (−10.7% year on year).

Earnings([Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-03-13· RCEPT 20260313900507

US$11.3MRevenue
+2.6%Revenue vs a year earlier
US$614KOperating profit

Converted at 1 USD ≈ ₩1,470.58 (filing-date rate, 2026-03-13 close)

What happened

Hass updated its previously filed consolidated results for FY2025: revenue of US$11.3M (+2.6% year on year), operating profit of US$614K (−27% year on year) and net income of US$1.09M (−10.7% year on year).

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$11.3M
Revenue vs a year earlier+2.6%
Operating profitUS$614K
Net incomeUS$1.09M
PeriodFY2025 (consolidated)
Filed2026-03-13, [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260313900507 → open original filing

Versions of this filing

  1. 2026-02-10Original
  2. 2026-03-13Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-13 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.